We are live on
!
Find out more
Corcept Therapeutics
CORT
CORT
135 hedge funds and large institutions have $387M invested in Corcept Therapeutics in 2016 Q4 according to their latest regulatory filings, with 40 funds opening new positions, 49 increasing their positions, 31 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
208% more first-time investments, than exits
New positions opened: 40 | Existing positions closed: 13
163% more call options, than puts
Call options by funds: $1.43M | Put options by funds: $545K
58% more repeat investments, than reductions
Existing positions increased: 49 | Existing positions reduced: 31
48.05% more ownership
Funds ownership: 0% → 48.05% (+48%)
27% more capital invested
Capital invested by funds: $305M → $387M (+$82.6M)
23% more funds holding
Funds holding: 110 → 135 (+25)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Holders
135
Holders Change
+25
Holders Change %
+22.73%
% of All Funds
3.38%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
40
Increased
49
Reduced
31
Closed
13
Calls
$1.43M
Puts
$545K
Net Calls
+$887K
Net Calls Change
+$326K
Top Buyers
Top Sellers
| 1 |
IA
Investor AB
Stockholm,
Sweden
|
-$3.61M |
| 2 |
ISL
Ingalls & Snyder LLC
New York
|
-$3.52M |
| 3 |
Boston Partners
Boston,
Massachusetts
|
-$2.18M |
| 4 |
DADC
D.A. Davidson & Co
Great Falls,
Montana
|
-$1.25M |
| 5 |
TIM
Thornburg Investment Management
Santa Fe,
New Mexico
|
-$1.06M |
